About macusoft

237 million people globally suffer long term eye diseases that lead to devastating sight loss if not monitored regularly and treated. Demand is soaring from an ageing population and the increase in diabetes to the point where even the most advanced health systems can’t cope. Consequently, cases of sight loss amongst patients are increasing due primarily to delayed treatment.

Macusoft has developed an artificial intelligence (AI) clinical decision support system for the optimal management of preventable sight threatening eye conditions. Treatment is tailored to each individual patient and delivered at the point-of-care for the best possible outcome.

The AI system is cloud-based and can be deployed rapidly at scale across health systems to alleviate the overburden in eye departments and reduce unnecessary sight loss.

Welcome to macusoft.

Using genomic, clinical and imaging data, we can predict the optimal treatment plan by individual patient at the point-of-care for the best outcome.

Digital imaging and patient data has enabled us to build artificial intelligence (AI) that can be trained to deliver specific tasks at far higher accuracy than is humanly possible. Applying deep learning to large volumes of image and patient data enables us to deliver treatment options that are evidence-based.

This is the beginning of a journey to build a portfolio of digital AI interventions that unlock global healthcare opportunities and help build a better tomorrow.